Growthink Research's Healthcare Venture Capital Report (2Q 03)

Growthink Research’s Healthcare Venture Capital Report (2Q 03) analyzes and profiles the 116 healthcare companies that raised venture capital in the second quarter of 2003 (representing $1.1 billion) and more than 185 investors that funded them. All company and investor profiles include complete contact information.

The report is organized by 4 key sectors:

• Biotechnology/Pharmaceutical
• Diagnostic/Patient Care
• Healthcare Software & Services
• Medical Devices

The Report provides many benefits to several audiences:

• Early Stage Ventures: unique insight into the funding market; identification of the best investors to target; identification of potential partners; critical competitive intelligence.



• Venture Capitalists: critical competitive intelligence for decision-making regarding current portfolio and new investments.



• Mid-Stage and Late-Stage/Fortune 500 Companies: critical competitive intelligence and identification of potential ventures to invest in, partner with, or acquire.



• Product & Service Providers: identification of the most promising ventures that could use your products and services.